Results 181 to 190 of about 7,268 (257)

Exploring Scaffold Hopping for Novel 2-(Quinolin-4-yloxy)acetamides with Enhanced Antimycobacterial Activity. [PDF]

ACS Med Chem Lett
Borsoi AF, Silva Ramos A, Sperotto N, Abbadi BL, Souza Macchi Hopf F, da Silva Dadda A, Scheibler Rambo R, Neves Muniz M, Delgado Paz J, Silveira Grams E, Fries da Silva F, Pissinate K, Galina L, Calle González L, Silva Duarte L, Alberton Perelló M, de Matos Czeczot A, Bizarro CV, Basso LA, Machado P.   +19 more
europepmc   +1 more source

Synthesis and Microbiological Activities of 3-Nitropyrazolo-[1,5-d][1,2,4]triazin-7(6<i>H</i>)-ones and Derivatives. [PDF]

Molecules
Zapol'skii VA, Munoz Castillo DC, Pawletta B, Bilitewski U, Gjikaj M, Brüdigam C, Kaufmann DE.   +6 more
europepmc   +1 more source

Thio-NHS esters are non-innocent protein acylating reagents. [PDF]

Nat Commun
Liu W, Khan A, Demyanenko Y, Mohammed S, Davis BG.   +4 more
europepmc   +1 more source

Synthesis of N-CD₃ aryl amines <i>via</i> iron-catalysed site-selective aromatic C-H amination. [PDF]

Chem Sci
Ren MM, Yang Y, Wang F.
europepmc   +1 more source

Efficient construction of functionalized pyrroloindolines through cascade radical cyclization/intermolecular coupling. [PDF]

Chem Sci
Jiang Y, Liu D, Zhang L, Qin C, Li H, Yang H, Walsh PJ, Yang X.   +7 more
europepmc   +1 more source

Author Correction: Aryl amino acetamides prevent Plasmodium falciparum ring development via targeting the lipid-transfer protein PfSTART1. [PDF]

Nat Commun
Dans MG, Boulet C, Watson GM, Nguyen W, Dziekan JM, Evelyn C, Reaksudsan K, Mehra S, Razook Z, Geoghegan ND, Mlodzianoski MJ, Goodman CD, Ling DB, Jonsdottir TK, Tong J, Famodimu MT, Kristan M, Pollard H, Stewart LB, Brandner-Garrod L, Sutherland CJ, Delves MJ, McFadden GI, Barry AE, Crabb BS, de Koning-Ward TF, Rogers KL, Cowman AF, Tham WH, Sleebs BE, Gilson PR.   +30 more
europepmc   +1 more source

Safety and feasibility of liver maximum capacity assessment in patients undergoing transarterial chemoembolisation for hepatocellular carcinoma. [PDF]

Sci Rep
Clarke G, Dhanaraj S, Hull D, Panton M, Mergental H, Afford SC, Shetty S, Karkhanis S, Mehrzad H, Ma YT, Punia P, Shah T, Dasari BVM.   +12 more
europepmc   +1 more source

Identification of novel <i>Mycobacterium tuberculosis</i> leucyl-tRNA synthetase inhibitors with antibacterial activity. [PDF]

Future Med Chem
Volynets GP, Gudzera OI, Lukashov SS, Gorbatiuk OB, Usenko MO, Ruban TP, Protopopov MV, Tarnavskiy SS, Kotey IM, Bdzhola VG, Prykhod'ko AO, Lukash LL, Yarmoluk SM, Tukalo MA.   +13 more
europepmc   +1 more source

Enzymatic, cell-based, and <i>in silico</i> evaluation of di-substituted aminomethyl-1,2,3-triazole-cinamamide hybrids as mushroom tyrosinase inhibitors. [PDF]

RSC Adv
Dastyafteh N, Sayahi MH, Morshedsolouk MH, Safapoor S, Mahdavi M, Saeedi M, Hamedifar H, Sepehri N, Iraji A.   +8 more
europepmc   +1 more source

Physical compatibility of omadacycline with intravenous agents used in the treatment of Mycobacteroides abscessus pulmonary disease. [PDF]

Am J Health Syst Pharm
Butler DA, Moolick K.
europepmc   +1 more source